IL107155A - Esters of acylsulfonamide - and sulfonamidopyridine-2 carboxylic acid and their pyridine N-oxides, methods for their preparation and use as drugs - Google Patents

Esters of acylsulfonamide - and sulfonamidopyridine-2 carboxylic acid and their pyridine N-oxides, methods for their preparation and use as drugs

Info

Publication number
IL107155A
IL107155A IL10715593A IL10715593A IL107155A IL 107155 A IL107155 A IL 107155A IL 10715593 A IL10715593 A IL 10715593A IL 10715593 A IL10715593 A IL 10715593A IL 107155 A IL107155 A IL 107155A
Authority
IL
Israel
Prior art keywords
amino
pyridine
carbonyl
carboxylate example
ethyl
Prior art date
Application number
IL10715593A
Other languages
English (en)
Hebrew (he)
Other versions
IL107155A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL107155A0 publication Critical patent/IL107155A0/xx
Publication of IL107155A publication Critical patent/IL107155A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL10715593A 1992-10-02 1993-09-29 Esters of acylsulfonamide - and sulfonamidopyridine-2 carboxylic acid and their pyridine N-oxides, methods for their preparation and use as drugs IL107155A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4233124A DE4233124A1 (de) 1992-10-02 1992-10-02 Acylsulfonamido- und Sulfonamidopyridin-2-carbonsäureester sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
IL107155A0 IL107155A0 (en) 1993-12-28
IL107155A true IL107155A (en) 1999-09-22

Family

ID=6469456

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10715593A IL107155A (en) 1992-10-02 1993-09-29 Esters of acylsulfonamide - and sulfonamidopyridine-2 carboxylic acid and their pyridine N-oxides, methods for their preparation and use as drugs

Country Status (25)

Country Link
US (1) US5428046A (es)
EP (1) EP0590520B1 (es)
JP (1) JPH06211795A (es)
KR (1) KR940009156A (es)
CN (1) CN1089603A (es)
AT (1) ATE139227T1 (es)
AU (1) AU662448B2 (es)
CA (1) CA2107514A1 (es)
CZ (1) CZ283869B6 (es)
DE (2) DE4233124A1 (es)
DK (1) DK0590520T3 (es)
ES (1) ES2090806T3 (es)
FI (1) FI103881B (es)
GR (1) GR3020230T3 (es)
HK (1) HK1006713A1 (es)
HU (1) HUT67292A (es)
IL (1) IL107155A (es)
MY (1) MY110277A (es)
NO (1) NO180085C (es)
NZ (1) NZ248819A (es)
PH (1) PH30677A (es)
PL (1) PL176772B1 (es)
RU (1) RU2117660C1 (es)
TW (1) TW258733B (es)
ZA (1) ZA937298B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
DE19742951A1 (de) * 1997-09-29 1999-04-15 Hoechst Schering Agrevo Gmbh Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
TW201512171A (zh) 2013-04-19 2015-04-01 Pfizer Ltd 化學化合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3432094A1 (de) * 1984-08-31 1986-03-06 Hoechst Ag, 6230 Frankfurt Ester der pyridin-2,4- und -2,5- dicarbonsaeure als arzneimittel zur inhibierung der prolin- und lysinhydroxylase
DE3703963A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben, sowie arzneimittel auf basis dieser verbindungen
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3703962A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE3707429A1 (de) * 1987-03-07 1988-09-15 Hoechst Ag Substituierte pyridin-2,4-dicarbonsaeure-derivate, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung
DE4031000A1 (de) * 1990-10-01 1992-04-09 Hoechst Ag 4- oder 5-substituierte pyridin-2-carbonsaeuren, verfahren zu deren herstellung sowie deren verwendung als arzneimittel

Also Published As

Publication number Publication date
NO180085B (no) 1996-11-04
PL176772B1 (pl) 1999-07-30
IL107155A0 (en) 1993-12-28
KR940009156A (ko) 1994-05-20
PH30677A (en) 1997-09-16
CZ204493A3 (en) 1994-05-18
CN1089603A (zh) 1994-07-20
GR3020230T3 (en) 1996-09-30
FI934303A (fi) 1994-04-03
HK1006713A1 (en) 1999-03-12
CA2107514A1 (en) 1994-04-03
US5428046A (en) 1995-06-27
EP0590520A1 (de) 1994-04-06
PL300561A1 (en) 1994-04-05
EP0590520B1 (de) 1996-06-12
NO180085C (no) 1997-02-12
DE4233124A1 (de) 1994-04-07
HUT67292A (en) 1995-03-28
DK0590520T3 (da) 1996-10-14
HU9302778D0 (en) 1993-12-28
ZA937298B (en) 1994-04-25
NO933521D0 (no) 1993-10-01
NO933521L (no) 1994-04-05
DE59302898D1 (de) 1996-07-18
FI103881B1 (fi) 1999-10-15
FI934303A0 (fi) 1993-09-30
AU4872693A (en) 1994-04-14
ES2090806T3 (es) 1996-10-16
CZ283869B6 (cs) 1998-06-17
ATE139227T1 (de) 1996-06-15
FI103881B (fi) 1999-10-15
AU662448B2 (en) 1995-08-31
MY110277A (en) 1998-03-31
RU2117660C1 (ru) 1998-08-20
NZ248819A (en) 1996-02-27
TW258733B (es) 1995-10-01
JPH06211795A (ja) 1994-08-02

Similar Documents

Publication Publication Date Title
US5658933A (en) Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
CA2092276A1 (en) Sulfonamido- and sulfonamidocarbonylpyridine -2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals
EP0650961B1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
US5610172A (en) Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals
US5620996A (en) Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals
EP0661269B1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
KR20100068453A (ko) 치환된 니코틴아미드 화합물 및 약제학적 제품에서 이의 용도
CA2145473A1 (en) Substituted heterocyclic carboxamidoesters their preparation and their use as pharmaceuticals
CA2078590A1 (en) 2-hydroxymethylpyridines, the corresponding pyridine n-oxides and their derivatives, processes for their preparation and their use
IL107155A (en) Esters of acylsulfonamide - and sulfonamidopyridine-2 carboxylic acid and their pyridine N-oxides, methods for their preparation and use as drugs
CA2095206A1 (en) 4- or 5-(sulf)imido- and -(sulfon)amidopyridines and their pyridine n-oxides, processes for their preparation, and their use as medicaments
WO2014082737A1 (en) Specific carboxamides as kcnq2/3 modulators
CA2145472A1 (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
DE4433928A1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE4410881A1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
DE4434288A1 (de) Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
DE4337270A1 (de) Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH1 Patent not in force